v3.25.3
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
3 Months Ended 4 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2025
Feb. 28, 2025
Aug. 31, 2024
Feb. 29, 2024
Nov. 30, 2023
Aug. 31, 2025
Aug. 31, 2024
Nov. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:                
Net loss $ (4,736) $ (9,391) $ (21,142) $ (3,702) $ (5,520) $ (25,772) $ (28,440)  
Adjustment to reconcile net loss to net cash provided by operating activities:                
Depreciation expenses           459 435 $ 588
Changes in operating assets and liabilities:                
Prepayments and deposit           4,154 (4,476)  
Accrued liabilities           (6,400) (650)  
Amount due to a director           13,461  
Amount due from a shareholder           20,703  
Deferred revenue           (1,000) 900  
Net cash used in operating activities           (7,856) (18,770)  
CASH FLOWS FROM INVESTING ACTIVITY:                
Purchase of plant and equipment           (729)  
Net cash used in investing activity           (729)  
CASH FLOWS FROM FINANCING ACTIVITY:                
Share application money pending allotment           30,900  
Net cash provided by financing activity           30,900  
Effect of exchange rate changes on cash and cash equivalents           (314) (550)  
Net (decrease)/increase in cash and cash equivalents           (8,170) 10,851  
Cash and cash equivalents, beginning of period   $ 10,341   $ 7,319   10,341 7,319 7,319
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 2,171   $ 18,170   $ 7,319 2,171 18,170 $ 10,341
SUPPLEMENTAL CASH FLOWS INFORMATION                
Income taxes paid            
Interest paid